|
1
|
Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness.
|
Blood
|
2004
|
4.04
|
|
2
|
Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation.
|
Blood
|
2003
|
1.78
|
|
3
|
Evidence for skeletal progenitor cells in the degenerate human intervertebral disc.
|
Spine (Phila Pa 1976)
|
2007
|
1.60
|
|
4
|
Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells.
|
Stem Cells
|
2006
|
1.30
|
|
5
|
Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration.
|
Tissue Eng
|
2006
|
1.23
|
|
6
|
Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system.
|
Mol Ther
|
2004
|
1.17
|
|
7
|
Nonvirally engineered porcine adipose tissue-derived stem cells: use in posterior spinal fusion.
|
Stem Cells
|
2008
|
1.13
|
|
8
|
The use of a synthetic oxygen carrier-enriched hydrogel to enhance mesenchymal stem cell-based bone formation in vivo.
|
Biomaterials
|
2009
|
1.09
|
|
9
|
Microcomputed tomography-based structural analysis of various bone tissue regeneration models.
|
Nat Protoc
|
2011
|
1.03
|
|
10
|
Maxillofacial-derived stem cells regenerate critical mandibular bone defect.
|
Tissue Eng Part A
|
2008
|
1.00
|
|
11
|
PTH promotes allograft integration in a calvarial bone defect.
|
Mol Pharm
|
2013
|
0.99
|
|
12
|
Molecular imaging of the skeleton: quantitative real-time bioluminescence monitoring gene expression in bone repair and development.
|
J Bone Miner Res
|
2003
|
0.96
|
|
13
|
Stem cell-based therapy for prevention of delayed fracture union: a randomized and prospective preliminary study.
|
Mol Ther
|
2013
|
0.96
|
|
14
|
Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures.
|
Tissue Eng Part B Rev
|
2010
|
0.95
|
|
15
|
Gene-modified adult stem cells regenerate vertebral bone defect in a rat model.
|
Mol Pharm
|
2011
|
0.95
|
|
16
|
Targeted gene-and-host progenitor cell therapy for nonunion bone fracture repair.
|
Mol Ther
|
2010
|
0.94
|
|
17
|
Genetically modified cells in regenerative medicine and tissue engineering.
|
Adv Drug Deliv Rev
|
2010
|
0.93
|
|
18
|
Smad8/BMP2-engineered mesenchymal stem cells induce accelerated recovery of the biomechanical properties of the Achilles tendon.
|
J Orthop Res
|
2012
|
0.87
|
|
19
|
Future uses of mesenchymal stem cells in spine surgery.
|
Neurosurg Focus
|
2005
|
0.86
|
|
20
|
Patterning osteogenesis by inducible gene expression in microfluidic culture systems.
|
Integr Biol (Camb)
|
2010
|
0.86
|
|
21
|
Oxygenated environment enhances both stem cell survival and osteogenic differentiation.
|
Tissue Eng Part A
|
2013
|
0.84
|
|
22
|
Nucleus pulposus degeneration alters properties of resident progenitor cells.
|
Spine J
|
2013
|
0.83
|
|
23
|
Bioluminescent imaging in bone.
|
Methods Mol Biol
|
2008
|
0.82
|
|
24
|
Adeno-associated virus-coated allografts: a novel approach for cranioplasty.
|
J Tissue Eng Regen Med
|
2012
|
0.82
|
|
25
|
Cell-mediated gene therapy for bone formation and regeneration.
|
Curr Opin Mol Ther
|
2002
|
0.81
|
|
26
|
Advanced molecular profiling in vivo detects novel function of dickkopf-3 in the regulation of bone formation.
|
J Bone Miner Res
|
2006
|
0.80
|
|
27
|
Design of a filamentous polymeric scaffold for in vivo guided angiogenesis.
|
Tissue Eng
|
2006
|
0.80
|
|
28
|
In vivo bioluminescent tracking of mesenchymal stem cells within large hydrogel constructs.
|
Tissue Eng Part C Methods
|
2014
|
0.78
|
|
29
|
Transient overexpression of Pparγ2 and C/ebpα in mesenchymal stem cells induces brown adipose tissue formation.
|
Regen Med
|
2013
|
0.76
|
|
30
|
The effect of ex vivo dynamic loading on the osteogenic differentiation of genetically engineered mesenchymal stem cell model.
|
J Tissue Eng Regen Med
|
2010
|
0.75
|
|
31
|
Real-time bioluminescence functional imaging for monitoring tissue formation and regeneration.
|
Methods Mol Biol
|
2013
|
0.75
|